Yvette Mettey

1.4k total citations
36 papers, 1.1k citations indexed

About

Yvette Mettey is a scholar working on Pulmonary and Respiratory Medicine, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Yvette Mettey has authored 36 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 14 papers in Organic Chemistry and 11 papers in Molecular Biology. Recurrent topics in Yvette Mettey's work include Cystic Fibrosis Research Advances (16 papers), Neonatal Respiratory Health Research (6 papers) and Synthesis and Reactions of Organic Compounds (6 papers). Yvette Mettey is often cited by papers focused on Cystic Fibrosis Research Advances (16 papers), Neonatal Respiratory Health Research (6 papers) and Synthesis and Reactions of Organic Compounds (6 papers). Yvette Mettey collaborates with scholars based in France, Italy and United Kingdom. Yvette Mettey's co-authors include Frédéric Becq, J.‐M. VIERFOND, Caroline Norez, Laurent Meijer, Luis J. V. Galietta, Renaud Dérand, Stéphane Bach, Hervé Galons, Pierre Launay and Marc Blondel and has published in prestigious journals such as Journal of Biological Chemistry, Nature Biotechnology and Journal of Cell Science.

In The Last Decade

Yvette Mettey

34 papers receiving 1.1k citations

Peers

Yvette Mettey
Steven J. Feinmark United States
E. Highland United States
Heather E. Murrey United States
David H. Reifsnyder United States
Steven J. Feinmark United States
Yvette Mettey
Citations per year, relative to Yvette Mettey Yvette Mettey (= 1×) peers Steven J. Feinmark

Countries citing papers authored by Yvette Mettey

Since Specialization
Citations

This map shows the geographic impact of Yvette Mettey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yvette Mettey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yvette Mettey more than expected).

Fields of papers citing papers by Yvette Mettey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yvette Mettey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yvette Mettey. The network helps show where Yvette Mettey may publish in the future.

Co-authorship network of co-authors of Yvette Mettey

This figure shows the co-authorship network connecting the top 25 collaborators of Yvette Mettey. A scholar is included among the top collaborators of Yvette Mettey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yvette Mettey. Yvette Mettey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Norez, Caroline, Frédéric Bilan, Alain Kitzis, Yvette Mettey, & Frédéric Becq. (2008). Proteasome-Dependent Pharmacological Rescue of Cystic Fibrosis Transmembrane Conductance Regulator Revealed by Mutation of Glycine 622. Journal of Pharmacology and Experimental Therapeutics. 325(1). 89–99. 22 indexed citations
2.
Grand, Teddy, Marie Demion, Caroline Norez, et al.. (2008). 9‐Phenanthrol inhibits human TRPM4 but not TRPM5 cationic channels. British Journal of Pharmacology. 153(8). 1697–1705. 130 indexed citations
3.
Noël, Sabrina, Pierre‐Olivier Strale, Luc Dannhoffer, et al.. (2007). Stimulation of salivary secretion in vivo by CFTR potentiators in Cftr+/+ and Cftr−/− mice. Journal of Cystic Fibrosis. 7(2). 128–133. 14 indexed citations
4.
Noël, Sabrina, et al.. (2006). Discovery of Pyrrolo[2,3-b]pyrazines Derivatives as Submicromolar Affinity Activators of Wild Type, G551D, and F508del Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channels. Journal of Pharmacology and Experimental Therapeutics. 319(1). 349–359. 36 indexed citations
5.
Vandebrouck, Clarisse, Patricia Melin, Caroline Norez, et al.. (2006). Evidence that CFTR is expressed in rat tracheal smooth muscle cells and contributes to bronchodilation. Respiratory Research. 7(1). 113–113. 52 indexed citations
6.
Dechecchi, Maria Cristina, Elena Nicolis, Valentino Bezzerri, et al.. (2006). MPB-07 Reduces the Inflammatory Response to Pseudomonas aeruginosa in Cystic Fibrosis Bronchial Cells. American Journal of Respiratory Cell and Molecular Biology. 36(5). 615–624. 34 indexed citations
7.
Robert, Renaud, Vincent Thoreau, Caroline Norez, et al.. (2004). Regulation of the Cystic Fibrosis Transmembrane Conductance Regulator Channel by β-Adrenergic Agonists and Vasoactive Intestinal Peptide in Rat Smooth Muscle Cells and Its Role in Vasorelaxation. Journal of Biological Chemistry. 279(20). 21160–21168. 45 indexed citations
8.
Bach, Stéphane, Nicolas Talarek, Thibault Andrieu, et al.. (2003). Isolation of drugs active against mammalian prions using a yeast-based screening assay. Nature Biotechnology. 21(9). 1075–1081. 155 indexed citations
9.
Zegarra‐Moran, Olga, Leila Romio, Chiara Folli, et al.. (2002). Correction of G551D‐CFTR transport defect in epithelial monolayers by genistein but not by CPX or MPB‐07. British Journal of Pharmacology. 137(4). 504–512. 49 indexed citations
10.
Olivier, Jean‐Christophe, et al.. (2002). Photodegradation study of a new activator of the cystic fibrosis chloride channel, the 6‐hydroxy‐10‐chlorobenzo[c]quinolizinium chloride (MPB‐07). Journal of Pharmaceutical Sciences. 91(2). 324–330. 1 indexed citations
11.
Dormer, Robert L., Mark R. Morris, Mandy Pereira, et al.. (2001). Localisation of wild-type and ?F508-CFTR in nasal epithelial cells. Pflügers Archiv - European Journal of Physiology. 443(0). S117–S120. 13 indexed citations
12.
Dérand, Renaud, Yvette Mettey, Olga Zegarra‐Moran, et al.. (2001). Activation of G551D CFTR channel with MPB-91: regulation by ATPase activity and phosphorylation. American Journal of Physiology-Cell Physiology. 281(5). C1657–C1666. 40 indexed citations
13.
Chappe, Valérie, Yvette Mettey, J.‐M. VIERFOND, et al.. (1998). Structural basis for specificity and potency of xanthine derivatives as activators of the CFTR chloride channel. British Journal of Pharmacology. 123(4). 683–693. 53 indexed citations
14.
Mettey, Yvette, et al.. (1997). Benzo[c]quinoliziniums: A new family of inhibitors for protein kinase CK II. Bioorganic & Medicinal Chemistry Letters. 7(8). 961–964. 10 indexed citations
15.
Loiseau, Philippe M., Yvette Mettey, & J.‐M. VIERFOND. (1996). Antifilarial and trypanocidal properties of phenothiazines and related polycyclics as new lead structures. International Journal for Parasitology. 26(10). 1115–1117. 14 indexed citations
16.
Mettey, Yvette, et al.. (1996). Preparation of 1H-2,3,4,5-Tetraarylpyrroles by oxidation of heterocyclic imine-enamines. Synthetic Communications. 26(4). 793–802. 2 indexed citations
17.
VIERFOND, J.‐M. & Yvette Mettey. (1993). A Novel Synthetic Route to Cyanophenothiazines. First Example of Smiles Rearrangement from Halogenobenzonitriles. Heterocycles. 36(5). 987–987. 5 indexed citations
18.
VIERFOND, J.‐M., et al.. (1989). Reactions selectives de l'o.chlorobenzontrile : SNAr. Tetrahedron Letters. 30(8). 935–936. 3 indexed citations
19.
Métayé, Thierry, et al.. (1988). Comparative inhibition of human alkaline phosphatase and diamine oxidase by bromo-levamisole, cimetidine and various derivatives. Biochemical Pharmacology. 37(22). 4263–4268. 16 indexed citations
20.
Mettey, Yvette, et al.. (1983). Action d'organolithiens sur la méthyl‐2 quinoxaline. Etude de la réactivité des adduits. Journal of Heterocyclic Chemistry. 20(1). 133–137. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026